EyePoint Pharmaceuticals (NASDAQ:EYPT) reported quarterly losses of $(0.52) per share which met the analyst consensus estimate. This is a 23.81 percent decrease over losses of $(0.42) per share from the same period last year. The company reported quarterly sales of $11.56 million which beat the analyst consensus estimate of $10.87 million by 6.39 percent. This is a 28.31 percent increase over sales of $9.01 million the same period last year.
US Congressman Says Bitcoin Creator ‘Saratoshi Nagamoto’ Was Not Innovative, Dogecoin Co-Creator Responds
During a crypto hearing before the Financial Services Committee, U.S. Congressman Brad Sherman referred to the pseudonymous creator of Bitcoin (CRYPTO: BTC) as “Saratoshi Nagamoto” instead of Satoshi Nakamoto.
